Skip to main content

Melissa Angell

Articles From This Author

Why You Can Thank Millennials for the Booming $70 Billion Pet Industry
HEALTH
AMZN

Why You Can Thank Millennials for the Booming $70 Billion Pet Industry

By Melissa Angell
Aug 8, 2017 5:14 PM EDT
Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire
HEALTH
PFEAGNTEVA

Cramer: Every time I see Pfizer quarter, I recognize why they needed to do the Allergen deal

By Melissa Angell
Aug 7, 2017 12:13 PM EDT
Spicer Comments Rattle Marijuana Industry
HEALTH

Now That's a Switch: Longtime Tomato Grower to Fill Greenhouse With Weed

By Melissa Angell
Aug 5, 2017 1:40 PM EDT
Allergan Just Can't Break Through Despite a Ton of Positive Catalysts at Its Back
HEALTH
AGNPFE

$AGN posted $4 billion in revenue in the aesthetics division

By Melissa Angell
Aug 3, 2017 3:15 PM EDT
Will Chipotle Be Able to Wall Off Its Problems When It Reports Earnings?
OPINION
CMG

Here's How You Can Score a Free Burrito

By Melissa Angell
Aug 3, 2017 2:57 PM EDT
Bored With Cream and Sugar? You Can Now Add Weed to Your Morning Joe
HEALTH
TRTCSGBYPM

Bored With Cream and Sugar? You Can Now Add Weed to Your Morning Joe

By Melissa Angell
Aug 1, 2017 2:33 PM EDT
Twitter Stock Jumps After Mark Cuban Buys Shares
INVESTING
AAPL

Billionaire Mark Cuban: The Rise of Technology Will Cause a Lot of Unemployment

By Melissa Angell
Jul 31, 2017 4:43 PM EDT
Pfizer Investors Keep Eyes on Pipeline as Viagra, Lyrica Approach Patent Cliff
HEALTH
PFEAZNBMY

The Pharma Giant Reports its Earnings Tomorrow Morning.

By Melissa Angell
Jul 31, 2017 4:03 PM EDT
Teamsters Wary of McKesson's Promise to Split Top Roles
HEALTH
MCK

Teamsters Wary of McKesson's Promise to Split Top Roles

By Melissa Angell
Jul 27, 2017 5:59 PM EDT
Now, You Can Buy Shares of Popular Pro-Pot Periodical High Times
HEALTH
OACQ

Now, You Can Buy Shares of Popular Pro-Pot Periodical High Times

By Melissa Angell
Jul 27, 2017 3:59 PM EDT
Teamsters Mark Victory Against Executive Pay at Drug Titan McKesson
MERGERS AND ACQUISITIONS
MCKCAHABC

The "vote no" campaign led by the International Brotherhood of Teamsters against $MCK succeeds

By Melissa Angell
Jul 27, 2017 8:04 AM EDT
Universal Health Services Upgraded at Mizuho, Stock Rises as Obamacare Remains
MERGERS AND ACQUISITIONS
THCCHYHCA

Hospital Operators Sink Amid Healthcare Confusion

By Melissa Angell
Jul 25, 2017 3:04 PM EDT
Eyes Are on McKesson's Guidance
HEALTH
MCKCAHABC

Teamsters to Protest McKesson's Shareholder Meeting Wednesday

By Melissa Angell
Jul 24, 2017 4:57 PM EDT
Gene Editing Company Joins NASDAQ, Jumps Over 20% on First Day
HEALTH
BAYNMONCLLS

Gene Editing Company Joins NASDAQ, Jumps Over 20% on First Day

By Melissa Angell
Jul 21, 2017 12:26 PM EDT
European Pharma Companies Slip on MS Pricing Probe
HEALTH
KALA

Kala Pharmaceuticals Joins NASDAQ, the Biotech IPOs Keep Coming

By Melissa Angell
Jul 20, 2017 11:36 AM EDT
Vertex Pharmaceuticals Stock Surging on Positive Trial Data
HEALTH
VRTXABBV

Some Analysts Predict Revenue to Triple

By Melissa Angell
Jul 19, 2017 1:04 PM EDT
P&G, Valeant Exemplify Wall Street's 'Overboarded' Problem; Musk Must Raise Funds
BANKRUPTCY
VRXCG

Valeant is working to repay some $30 billion in debt.

By Melissa Angell
Jul 17, 2017 6:20 PM EDT
Konica Minolta and Ambry Pair to Accelerate in a New Field—Precision Medicine
STOCKS
KNCAFIBM

Konica and Ambry Pairing to Accelerate Precision Medicine

By Melissa Angell
Jul 15, 2017 10:40 AM EDT
Konica Minolta and Ambry Pair to Accelerate in a New Field—Precision Medicine
MERGERS AND ACQUISITIONS
KNCAFIBM

Konica and Ambry Pairing to Accelerate Precision Medicine

By Melissa Angell
Jul 14, 2017 5:24 PM EDT
Healthcare Stocks Sliding on Talks of Revived 'Trumpcare' Bill
STOCKS
MGLNPMCQHC

Magellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health

By Melissa Angell
Jul 13, 2017 11:38 AM EDT
Bunge Stock Rises After It Hires JPMorgan and Shearman & Sterling to Defend Against Takeover Bid
HEALTH
CLLS

Move Over GMO's: IPO for Gene Editor Calyxt Launches Next Week

By Melissa Angell
Jul 10, 2017 5:09 PM EDT
Bristol-Myers 'Is Back' and Could Soar Another 14%
STOCKS
BMYMCK

Bristol Myers vies to be king of immune-boosting cancer drugs with new trial update

By Melissa Angell
Jul 9, 2017 8:38 PM EDT
Alexion Shares Drop Amid Executive Changes
HEALTH
PFEALXN

Alexion Can't Stay Out of the Spotlight

By Melissa Angell
Jul 7, 2017 4:35 PM EDT
10 Highest-Paying Jobs in 2016 If All You Care About Is Money
HEALTH
BGNECELGMCK

Celgene Enters PD1 Market with BeiGene Deal

By Melissa Angell
Jul 6, 2017 4:42 PM EDT
Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire
HEALTH
GSPFE

Pfizer has left the building

By Melissa Angell
Jul 6, 2017 4:14 PM EDT
Here's the Latest on Four New Biotech IPOs
STOCKS
ATXIMRSNALRN

Here's the Latest on Four New Biotech IPOs

By Melissa Angell
Jul 3, 2017 1:02 PM EDT
Martin Shkreli Kicked Off Twitter for Harassing Female Journalists Like Me
HEALTH
RTRXTWXOREX

"There is no longer any cash at the fund level" Shkreli wrote to his investors.

By Melissa Angell
Jun 30, 2017 3:07 PM EDT
Juror Selection In Martin Shkreli Case Drags Into a Third Day
STOCKS
RTRX

Could an exhaustive juror search be part of the Pharma Bro's master plan?

By Melissa Angell
Jun 28, 2017 3:46 PM EDT
Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case
CORPORATE GOVERNANCE
RTRX

Shkreli's Lawyer Attempts to Ban Press...Again

By Melissa Angell
Jun 27, 2017 12:13 PM EDT
Martin Shkreli Kicked Off Twitter for Harassing Female Journalists Like Me
HEALTH
MYLRTRX

The jury selection process for Shkreli's trial got underway Monday and is expected to continue Tues.

By Melissa Angell
Jun 26, 2017 6:39 PM EDT
Pharma Bro's Trial to Begin Monday
HEALTH
RTRX

Pharma Bro's Trial to Begin Today

By Melissa Angell
Jun 26, 2017 10:14 AM EDT
Merck Keytruda-Chemo ASCO '17 Update Shows Lung Cancer Survival Trend
HEALTH
LPTXMRK

Could Merck and Leap Union Be the One for Keytruda?

By Melissa Angell
Jun 24, 2017 5:00 PM EDT
Healthcare Stocks Mixed Following President Trump's Comments on Senate Bill
HEALTH

Breaking Down the Senate Healthcare Bill

By Melissa Angell
Jun 22, 2017 6:16 PM EDT
Walgreens Stock Lower in Premarket After Earnings, Revenue Miss
HEALTH

Hey Big Pharma, Meet the Better Care Reconciliation Act

By Melissa Angell
Jun 22, 2017 12:19 PM EDT
FDA Commissioner Takes on Big Pharma
STOCKS
TEVAAGNJNJ

FDA Commissioner Takes on Big Pharma

By Melissa Angell
Jun 21, 2017 5:17 PM EDT
French Authorities Suspend AB Science Clinical Trials, Days Before ALS Drug Data Reveal
HEALTH
NVSREGN

Regeneron Soars After Eye Drug Competitor Novartis Releases Positive Data

By Melissa Angell
Jun 20, 2017 5:50 PM EDT
Amazon, Whole Foods: The Deal That Almost Wasn't?
MERGERS AND ACQUISITIONS
WMTKRAMZN

Local NYC Grocers Unhappy with Amazon-Whole Foods Deal

By Melissa Angell
Jun 20, 2017 11:22 AM EDT
Medicinal Marijuana Company Doubles Revenue But Struggles to Break Even
STOCKS
MJNAWFMTRTC

These products from Medical Marijuana are legal in all 50 states

By Melissa Angell
Jun 17, 2017 12:20 PM EDT
Google and Novartis Back Medicxi's New $300 Million Fund
HEALTH
NVSGOOGLGSK

There's a new biotech fund out there... and it's got $300 million

By Melissa Angell
Jun 16, 2017 9:45 AM EDT
Exact Sciences in Talks to Buy Genomic Health - Report
HEALTH
EPZMGILDABBV

Epizyme's eventual rebound may show promise with results from cancer drug.

By Melissa Angell
Jun 15, 2017 4:10 PM EDT
AstraZeneca's Big Bet on Oncology May Finally Pay Off
HEALTH
RGLSGILDJNJ

AstraZeneca drops partnership with Regulus after ditching drug

By Melissa Angell
Jun 13, 2017 1:12 PM EDT
Patheon Stock Spikes After Being Purchased by Thermo Fisher for $7.2 Billion
HEALTH
TMOPKITECH

Who is next for TMO's insatiable M&A appetite?

By Melissa Angell
Jun 13, 2017 11:56 AM EDT
Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER
HEALTH
DEPOINSYJNJ

Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER

By Melissa Angell
Jun 9, 2017 5:20 PM EDT
How Siri, Cortana Technologies Are Making Their Way Into Hospitals
HEALTH
AMZNMSIBM

Here's the technology that big banks, doctors, and startups are all using

By Melissa Angell
Jun 7, 2017 4:49 PM EDT
Amgen Cholesterol Drug Cuts Risk of Heart Attack, Stroke but Not Enough to Quell Value Debate
HEALTH
AMGNLLYPFE

Amgen Wants to Boost Label on Powerhouse Repatha

By Melissa Angell
Jun 7, 2017 4:46 PM EDT
Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold
HEALTH
IARTJNJMDT

Can healthcare giant Integra continue to grow? Signs point to yes.

By Melissa Angell
Jun 4, 2017 12:20 PM EDT
Shanda Goes Active on Community Health
HEALTH
CYH

Community Health to Sell Hospitals in Pennsylvania

By Melissa Angell
May 30, 2017 6:38 PM EDT